Further £950,000 order from Agrale
Summary by AI BETAClose X
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").
16 April 2026
Equipmake Holdings plc
("Equipmake" or the "Company")
Further £950,000 order from Agrale
Equipmake, a market leader in engineering-driven differentiated electrification technologies, products and solutions for the off-highway, on-highway, and aerospace and defence sectors, is pleased to announce that the Company has received a further £950,000 order from Agrale S.A. ("Agrale") to supply electric drivetrain systems for nine Agrale buses of varying types for delivery during the Company's financial year ending 31 May 2027.
In September 2025, the Company announced an order for electric drivetrain systems for 50 Agrale buses which are now being successfully deployed in Buenos Aires. On the back of this successful deployment, Agrale placed a further order to cover an additional 23 buses in January 2026 and has now placed an order to cover a further nine buses. Equipmake is supplying Agrale with a fully integrated electric drivetrain system combining an electric motor, inverter, control systems, and battery pack, utilising both the Company's products and technology, together with components sourced from third parties.
Ian Foley, CEO of Equipmake, commented: "We are delighted to receive another order from Agrale, demonstrating the value they see in Equipmake systems for their buses in South America. This latest order means that they have now ordered nearly £9 million of Equipmake electric drivetrain systems since September last year. We look forward to continuing to build our relationship with Agrale based on our shared commitment to provide a robust sustainable transport network in the region."
For further information, please contact:
|
Equipmake Tim Metcalfe, Non-executive Chairman Ian Foley, CEO Ian Selby, CFO |
Via IFC |
|
VSA Capital (Financial Adviser, Aquis Corporate Adviser and Broker) Andrew Raca / Brian Wong |
Tel: +44 (0) 20 3005 5000
|
|
IFC Advisory (Financial PR and IR Adviser) Graham Herring / Zach Cohen |
Tel: +44 (0)20 3934 6632 equipmake@investor-focus.co.uk |
Sign up for Equipmake updates here: https://investors.equipmake.co.uk/auth/signup
About Equipmake
Equipmake is a UK-based industrial technology company specialising in the engineering, development and production of electrification products to meet the needs of the automotive and other sectors in support of the transition from fossil-fuelled to zero-emission drivetrains.
Equipmake is a leader in high performance technologically advanced electric motors, inverters and complete zero-emission electric drivetrains and power electronic systems. Equipmake has developed a vertically integrated solution providing fully bespoke solutions to its customers. The Company is focussed on accelerating traction with OEM and Tier 1 suppliers in relation to higher margin component and drivetrain supply under long-term growth contracts.
Key differentiators of the Company offerings are its advanced technology and performance, reliability and adherence to ASIL-D1 functional safety. Equipmake's advanced motor and inverter technology, featuring ASIL-D compliance, are designed to customers' highest functional safety standards. With decades of experience in electric drivetrain integration and a dedicated prototype vehicle testing facility, Equipmake can significantly accelerate product development for customers.
Further investor and background information may be found on the Company's website, including video interviews and interested parties can sign up to follow the company at:
https://investors.equipmake.co.uk/
1 Automotive Safety Integrity Level ("ASIL") is a risk classification scheme defined by the ISO 26262 - Functional Safety for Road Vehicles standard and is a critical requirement for road vehicles. Of the four ASILs identified by the standard, ASIL-D dictates the highest integrity requirements on the product, which require exceptional rigour in their development.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Johnson Matthey
- 12 hours ago Galliford Try
- 12 hours ago Galliford Try
- 12 hours ago Centrica
- 13 hours ago Smith & Nephew